Stratrix
On the Record · Vertex Pharmaceuticals Inc / MA

Vertex Pharmaceuticals Inc / MA subsidiaries, as it lists them

The subsidiaries Vertex Pharmaceuticals Inc / MA lists in its latest annual report, with the jurisdiction of each, linked to the filing.

Subsidiaries it lists

SubsidiaryJurisdiction
Vertex Pharmaceuticals (San Diego) LLCDelaware
Vertex Pharmaceuticals (Distribution) IncorporatedDelaware
Vertex Pharmaceuticals LimitedCayman Islands
Vertex Pharmaceuticals (Delaware) LLCDelaware
Vertex Pharmaceuticals (Puerto Rico) LLCDelaware
Vertex Pharmaceuticals (Canada) IncorporatedCanada
Vertex Holdings, Inc.Delaware
Vertex Pharmaceuticals (Europe) LimitedUnited Kingdom
Vertex Pharmaceuticals (Ireland) LimitedIreland
Vertex Pharmaceuticals (France) SASFrance
Vertex Pharmaceuticals (Germany) GmbHGermany
Vertex Pharmaceuticals (Australia) Pty. Ltd.Australia
Vertex Pharmaceuticals (Spain), S.L.Spain
Vertex Pharmaceuticals (Netherlands) B.V.Netherlands
Vertex Pharmaceuticals (Italy) S.r.L.Italy
Vertex Farmaceutica do Brasil LTDABrazil
Vertex Pharmaceuticals GmbHAustria
Vertex Pharmaceuticals (Portugal), Unipessoal Lda.Portugal
Vertex Pharmaceuticals (CH) GmbH—
Vertex Pharmaceuticals (Sweden) ABSweden
Vertex Pharmaceuticals Single Member Societe Anonyme—
Vertex Pharmaceuticals (Poland) sp. z.o.o.Poland
The Vertex Foundation, Inc.Delaware
Torreyana Insurance Company, Inc.Vermont
Vertex Pharmaceuticals (Czech Republic) s.r.oCzech Republic
Vertex Pharmaceuticals (Belgium) BVBelgium
Vertex Pharmaceuticals Limited d.o.o. BeogradSerbia
Company for Services and Trade VERTEX PHARMACEUTICALS DOOEL SkopjeNorth Macedonia
Plum Cove Capital LLCDelaware
ViaCyte, Inc.Delaware
Vertex Pharmaceuticals (Chile) SpAChile
Vertex Holdings U.S. LLCDelaware
Vertex Pharmaceuticals Mexico, S. de R.L. de C.V.Mexico
Vertex Pharmaceuticals UK Holdings LimitedUnited Kingdom
Alpine Immune Sciences, Inc.Delaware
AIS Operating Co., Inc.Delaware
Alpine Immune Sciences Australia Pty LtdAustralia
Vertex Pharmaceuticals LLCSaudi Arabia

From Exhibit 21 of the 10-K for 2025. Companies must list their significant subsidiaries there and may leave out smaller ones, so this is the company’s own list, not every entity it owns.

Read from Vertex Pharmaceuticals Inc / MA’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-13. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.